KRAS and TP53 co-mutation predicts benefit of immune checkpoint blockade in lung adenocarcinoma
KRAS 和 TP53 共突变可预测免疫检查点阻断对肺腺癌的益处
期刊:British Journal of Cancer
影响因子:6.4
doi:10.1038/s41416-024-02746-z
Jan Budczies, Eva Romanovsky, Martina Kirchner, Olaf Neumann, Miriam Blasi, Johannes Schnorbach, Rajiv Shah, Farastuk Bozorgmehr, Rajkumar Savai, Thorsten Stiewe, Solange Peters, Peter Schirmacher, Michael Thomas, Daniel Kazdal, Petros Christopoulos, Albrecht Stenzinger
